Chronic stable angina pectoris

Abstract
Preview In most patients with stable angina pectoris, symptoms can be controlled successfully with drug therapy. Revascularization procedures should be reserved for those at high risk for cardiac events and those who do not respond to optimal therapy with any of the three classes of antianginal agents. In this article, the authors describe tailoring of medical therapy on the basis of concomitant disease, outcome of risk stratification, and response to individual agents.

This publication has 25 references indexed in Scilit: